TG Therapeutics CEO Michael Weiss' 2019 pay slips 11% to $13M
TG Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
TG Therapeutics reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, two executives at TG Therapeutics received on average a compensation package of $6.7M, a 12% decrease compared to previous year.
Average pay of disclosed executives at TG Therapeutics
Michael S. Weiss, Chief Executive Officer, received $13M in total, which decreased by 11% compared to 2018. 66% of Weiss' compensation, or $8.4M, was in stock awards. Weiss also received $191K in non-equity incentive plan, $3.5M in option awards, as well as $637K in salary.
For fiscal year 2019, the median employee pay was $322,556 at TG Therapeutics. Therefore, the ratio of Michael S. Weiss' pay to the median employee pay was 39 to one.
Sean A. Power, Chief Financial Officer, received a compensation package of $816K, which decreased by 24% compared to previous year. 42% of the compensation package, or $345K, was in option awards.
Related executives
You may also like
Source: SEC filing on April 29, 2020.